Abstract
Background
Socioeconomic and racial differences have been associated with disparities in cancer care within the US, including disparate access to minimally invasive surgery for rectal cancer. We hypothesized that robotic approach to rectal cancer may be associated with similar disparities.
Methods
The National Cancer Database (NCDB) was used to identify patients over 18 years old with clinical stage I–III rectal adenocarcinoma who underwent a proctectomy between 2010 and 2014. Demographic and hospital factors were analyzed for association with robotic approach. Factors identified on bivariate analyses informed multivariate analysis.
Results
We identified 33,503 patients who met inclusion criteria; 3702 (11.1%) underwent robotic surgery with 7.8% conversion rate. Patients who received robotic surgery were more likely to be male, white, privately insured and with stage III cancer. They were also more likely to live in a metropolitan area, more than 25 miles away from the hospital and with a higher high school graduation rate. The treating hospital was more likely to be academic and high volume.
Conclusions
Robotic surgery is performed rarely and access to it is limited for patients who are female, black, older, non-privately insured and unable to travel to high-volume teaching institutions. The advantages of robotic surgery may not be available to all patients given disparate access to the robot. This inherent bias in access to robot may skew study populations, preventing generalizability of robotic surgery research.
Graphic abstract
Similar content being viewed by others
References
Lee DY, Teng A, Pedersen RC et al (2017) Racial and socioeconomic treatment disparities in adolescents and young adults with stage II–III rectal cancer. Ann Surg Oncol 24(2):311–318. https://doi.org/10.1245/s10434-016-5626-0
Turner M, Adam MA, Sun Z et al (2017) Insurance status, not race, is associated with use of minimally invasive surgical approach for rectal cancer. Ann Surg 265(4):774–781. https://doi.org/10.1097/SLA.0000000000001781
Ohtani H, Maeda K, Nomura S et al (2018) Meta-analysis of robot-assisted versus laparoscopic surgery for rectal cancer. Vivo 32(3):611–623. https://doi.org/10.21873/invivo.11283
Liao G, Li Y-B, Zhao Z, Li X, Deng H, Li G (2016) Robotic-assisted surgery versus open surgery in the treatment of rectal cancer: the current evidence. Sci Rep 6(1):26981. https://doi.org/10.1038/srep26981
Silva-Velazco J, Dietz DW, Stocchi L et al (2017) Considering value in rectal cancer surgery: an analysis of costs and outcomes based on the open, laparoscopic, and robotic approach for proctectomy. Ann Surg 265(5):960–968. https://doi.org/10.1097/SLA.0000000000001815
Kim J, ElRayes W, Wilson F et al (2015) Disparities in the receipt of robot-assisted radical prostatectomy: between-hospital and within-hospital analysis using 2009-2011 California inpatient data. BMJ Open 5(4):e007409. https://doi.org/10.1136/bmjopen-2014-007409
Price JT, Zimmerman LD, Koelper NC, Sammel MD, Lee S, Butts SF (2017) Social determinants of access to minimally invasive hysterectomy: reevaluating the relationship between race and route of hysterectomy for benign disease. Am J Obstet Gynecol 217(5):572.e1–572.e10. https://doi.org/10.1016/J.AJOG.2017.07.036
Turner MC, Adam MA, Sun Z et al (2018) Response to letter: comment on “insurance status, not race is associated with use of minimally invasive surgical approach for rectal cancer”. Ann Surg 267(2):e30. https://doi.org/10.1097/SLA.0000000000001974
Gabriel E, Thirunavukarasu P, Al-Sukhni E, Attwood K, Nurkin SJ (2016) National disparities in minimally invasive surgery for rectal cancer. Surg Endosc 30(3):1060–1067. https://doi.org/10.1007/s00464-015-4296-5
Harrop E, Kelly J, Griffiths G, Casbard A, Nelson A, Published on behalf of the BOLERO Trial Management Group (TMG) P on behalf of the BTMG (2016) Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy). Trials 17:35. https://doi.org/10.1186/s13063-016-1173-z
Jayne D, Pigazzi A, Marshall H et al (2017) Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer. JAMA 318(16):1569. https://doi.org/10.1001/jama.2017.7219
Ackerman SJ, Daniel S, Baik R et al (2018) Comparison of complication and conversion rates between robotic-assisted and laparoscopic rectal resection for rectal cancer: which patients and providers could benefit most from robotic-assisted surgery? J Med Econ 21(3):254–261. https://doi.org/10.1080/13696998.2017.1396994
D’Annibale A, Morpurgo E, Fiscon V et al (2004) Robotic and laparoscopic surgery for treatment of colorectal diseases. Dis Colon Rectum 47(12):2162–2168. https://doi.org/10.1007/s10350-004-0711-z
Moszkowicz D, Alsaid B, Bessede T et al (2011) Where does pelvic nerve injury occur during rectal surgery for cancer? Color Dis 13(12):1326–1334. https://doi.org/10.1111/j.1463-1318.2010.02384.x
Hyuk Baik S, Kyu Kim N, Young Lee K et al (2008) Factors influencing pathologic results after total mesorectal excision for rectal cancer: analysis of consecutive 100 cases. Ann Surg Oncol 15(3):721–728. https://doi.org/10.1245/s10434-007-9706-z
Fantus RJ, Cohen A, Riedinger CB et al (2018) Facility-level analysis of robot utilization across disciplines in the National Cancer Database. J Robot Surg. https://doi.org/10.1007/s11701-018-0855-9
Alkhateeb S, Lawrentschuk N (2011) Consumerism and its impact on robotic-assisted radical prostatectomy. BJU Int 108(11):1874–1878. https://doi.org/10.1111/j.1464-410X.2011.10117.x
Gomes P (2011) Surgical robotics: reviewing the past, analysing the present, imagining the future. Robot Comput Integr Manuf 27(2):261–266. https://doi.org/10.1016/J.RCIM.2010.06.009
Mallin K, Browner A, Palis B et al (2019) Incident cases captured in the national cancer database compared with those in U.S. Population Based Central Cancer Registries in 2012–2014. Ann Surg Oncol. https://doi.org/10.1245/s10434-019-07213-1
Acknowledgements
We acknowledge the support of the University Hospitals Cleveland Medical Center Surgery Department and UH-RISES: Research in Surgical Outcomes & Effectiveness Center.
Funding
This investigation was funded by the University Hospitals Cleveland Medical Center Surgery Department.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Dr. Stein has been a speaker for Merck and advisory consultant for Medtronics. Dr. Towe is a consultant for Medtronic, Atricure, Sig Medical, and Zimmer Biomet. Drs. Steinhagen, Bingmer and Ofshteyn have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ofshteyn, A., Bingmer, K., Towe, C.W. et al. Robotic proctectomy for rectal cancer in the US: a skewed population. Surg Endosc 34, 2651–2656 (2020). https://doi.org/10.1007/s00464-019-07041-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-019-07041-0